PLoS ONE (Jan 2021)

Description and analysis of representative COVID-19 cases-A retrospective cohort study.

  • Yannis Herrmann,
  • Tim Starck,
  • Niall Brindl,
  • Philip J Kitchen,
  • Lukas Rädeker,
  • Jakob Sebastian,
  • Lisa Köppel,
  • Frank Tobian,
  • Aurélia Souares,
  • André L Mihaljevic,
  • Uta Merle,
  • Theresa Hippchen,
  • Felix Herth,
  • Britta Knorr,
  • Andreas Welker,
  • Claudia M Denkinger

DOI
https://doi.org/10.1371/journal.pone.0255513
Journal volume & issue
Vol. 16, no. 7
p. e0255513

Abstract

Read online

BackgroundMost data on COVID-19 was collected in hospitalized cases. Much less is known about the spectrum of disease in entire populations. In this study, we examine a representative cohort of primarily symptomatic cases in an administrative district in Southern Germany.MethodsWe contacted all confirmed SARS-CoV-2 cases in the administrative district. Consenting participants answered a retrospective survey either via a telephone, electronically or via mail. Clinical and sociodemographic features were compared between hospitalized and non-hospitalized patients. Additionally, we assessed potential risk factors for hospitalization and time to hospitalization in a series of regression models.ResultsWe included 897 participants in our study, 69% out of 1,305 total cases in the district with a mean age of 47 years (range 2-97), 51% of which were female and 47% had a pre-existing illness. The percentage of asymptomatic, mild, moderate (leading to hospital admission) and critical illness (requiring mechanical ventilation) was 54 patients (6%), 713 (79%), 97 (11%) and 16 (2%), respectively. Seventeen patients (2%) died. The most prevalent symptoms were fatigue (65%), cough (62%) and dysgeusia (60%). The risk factors for hospitalization included older age (OR 1.05 per year increase; 95% CI 1.04-1.07) preexisting lung conditions (OR 3.09; 95% CI 1.62-5.88). Female sex was a protective factor (OR 0.51; 95% CI 0.33-0.77).ConclusionThis representative analysis of primarily symptomatic COVID-19 cases confirms age, male sex and preexisting lung conditions but not cardiovascular disease as risk factors for severe illness. Almost 80% of infection take a mild course, whereas 13% of patients suffer moderate to severe illness.Trial registrationGerman Clinical Trials Register, DRKS00022926. URL: https://www.drks.de/drks_web/setLocale_EN.do.